BOSTON--(BUSINESS WIRE)--
Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the
appointment of Michael J. Parini to the role of Executive Vice President
and Chief Legal Officer. Mr. Parini will serve as a member of Vertex's
Executive Committee, reporting directly to Jeffrey Leiden, M.D., Ph.D.,
Vertex's Chairman, President and Chief Executive Officer. Mr. Parini
will begin his role with Vertex effective January 4, 2016.
Mr. Parini joins Vertex after more than a decade at Pfizer Inc., where
he served in multiple leadership roles within the company's global legal
team. Most recently, he served as Senior Vice President and Associate
General Counsel and was responsible for the strategic management of
Pfizer's global litigation activities, including civil, intellectual
property, government and employment litigation. Mr. Parini also served
as Chief Counsel for multiple key business units within Pfizer, advising
Pfizer's leadership team on key business issues related to investment
decisions, patent disputes, global pricing strategies and commercial
operations activities, among other responsibilities.
"Michael brings to Vertex extensive global legal experience related to
the development and commercialization of multiple medicines," said Dr.
Leiden. "I welcome Michael to the Vertex team and believe his expertise
will be invaluable as we bring our cystic fibrosis medicines to more
people worldwide and advance key research and development programs
across many diseases."
"I've watched Vertex's evolution over recent years and am thrilled to
join this team at such an exciting and pivotal time in the company's
history," said Mr. Parini. "I believe that Vertex is one of very few
companies that has the potential to make a fundamental change in the
treatment of many serious diseases, and I look forward to joining the
team in January."
Prior to Pfizer, Mr. Parini served as a health care attorney at Akin,
Gump, Strauss, Hauer & Feld, L.L.P. where he provided legal counsel on
federal and state regulatory and policy issues. He is a member of the
New York and District of Columbia bars. He received a bachelor's degree
in American government from Georgetown University and his law degree
from Georgetown University Law.
About Vertex
Vertex is a global biotechnology company that aims to discover, develop
and commercialize innovative medicines so people with serious diseases
can lead better lives. In addition to our clinical development programs
focused on cystic fibrosis, Vertex has more than a dozen ongoing
research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and
development sites and commercial offices in the United
States, Europe, Canada and Australia. For six years in a row, Science magazine
has named Vertex one of its Top Employers in the life sciences. For
additional information and the latest updates from the company, please
visit www.vrtx.com.
(VRTX-GEN)
View source version on businesswire.com: http://www.businesswire.com/news/home/20151123005292/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael
Partridge, +1 617-341-6108
or
Eric Rojas, +1 617-961-7205
Or
Media:
617-341-6992
mediainfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
